Searchable abstracts of presentations at key conferences in endocrinology

ea0035p1021 | Thyroid (non-cancer) | ECE2014

Vitamin D levels in autoimmune thyroiditis and a control group among the Polish population

Maciejewski Adam , Wojcicka Marlena , Roszak Magdalena , Losy Jacek , Lacka Katarzyna

Introduction: Vitamin D, primarily known for its role in calcium–phosphorus homeostasis, is also a significant immunomodulatory factor. Vitamin D deficiency has been reported in some autoimmune disorders. Recently, vitamin D level in autoimmune thyroiditis (Hashimoto’s thyroiditis (HT)) has become the subject of researchers’ interest.Objectives: This study aims to assess vitamin 25-OH-D3 levels in HT patients in comparison to a control gro...

ea0035p1142 | Thyroid Cancer | ECE2014

Polymorphic pre-miR-146a and synergistic action of all of its products on NTRK2 gene in papillary thyroid carcinoma

Kubiak Anna , Wojcicka Anna , Wiechno Wieslaw , Niewinski Grzegorz , Jazdzewski Krystian

Objectives: Aberrances in expression and sequence of miR-146a have a well-established role in pathogenesis of papillary thyroid carcinoma (PTC). The G/C heterozygosity in rs2910164 of miR-146a underlies genetic predisposition to PTC and occurs as a somatic mutation in thyroid tumors. Deleterious function of rs2910164 consists in creation of a new variant of microRNA, resulting from the fact that a single microRNA precursor gives rise to −5p and −3p microRNAs. The S...

ea0063gp43 | Metabolic Syndrome and Hypoglycaemia | ECE2019

The elevated chemerin plasma concentrations in men diagnosed with metabolic syndrome are correlated with markers of low-grade state inflammation but not with SHBG serum levels and accompanying hypoandrogenemia.

Herman Waldemar , Jarecki Piotr , Kołodziejczak Barbara , Wojcicka Marlena , Losy Jacek , Łęcka Katarzyna

Background: Chemerin (CHEM) is a newly-discovered adipokine involved in the immune, metabolic and reproductive processes. Low-grade state inflammation (LGSI) is a key element in the pathogenesis of metabolic syndrome (MS).Objectives: The aim of the study was to assess the effect of age on MS prevalence, androgenic status as well as on selected inflammatory indices and CHEM plasma concentrations. Additionally we investigated correlations between CHEM and ...

ea0035p1121 | Thyroid Cancer | ECE2014

The role of microRNAs in regulation of RARβ and its function in development of papillary thyroid carcinoma

Czajka Agnieszka , Wojcicka Anna , Stachlewska Elzbieta , Wiechno Wieslaw , Niewinski Grzegorz , Jazdzewski Krystian

Objectives: Papillary thyroid carcinoma (PTC) exhibits aberrant expression of retinoic acid receptor β (RARβ), a retinoic acid-inducible transcription factor, essential for cellular growth and development. The mechanisms leading to decreased RARβ expression in tumors are unknown. We hypothesized that changes in expression of RARB, a gene encoding for RARβ, result from aberrant expression of microRNAs. We elucidated the miRNome of normal thyroid and...

ea0035p1123 | Thyroid Cancer | ECE2014

Sodium–iodide symporter and its microRNA-dependent deregulation in papillary thyroid carcinoma.

Kotlarek Marta , Gierlikowski Wojciech , Kubiak Anna , Maciag Monika , Jazdzewski Krystian , Wojcicka Anna

Objectives: The sodium/iodide symporter (NIS) is a glycoprotein with unique ability of transporting iodine into the thyroid follicle. Apart from the importance in thyroid hormone synthesis, this function of NIS allows the use of radioactive iodine to target residual and metastatic thyroid cancer after thyroidectomy. However, 20–30% of thyroid tumors exhibit lowered expression of NIS, resulting in decreased uptake of radioiodine and inefficient post-surgical therapy. Mecha...

ea0035p1125 | Thyroid Cancer | ECE2014

Apical iodide transporter and its microRNA-induced silencing in thyroid malignancies

Gierlikowski Wojciech , Kotlarek Marta , Bakula-Zalewska Elwira , Jazdzewski Krystian , Wojcicka Anna

Objectives: Apical iodide transporter (AIT) is essential for thyroid homeostasis, functioning both as iodide transporter and a potent tumor suppressor. Its decreased levels observed in thyroid cancer underlie its progression and inefficiency of radioactive iodine treatment, used for ablation of post-operative and metastatic thyroid cancer cells. Mechanisms of AIT downregulation in cancer are largely unknown, but recent data on overexpression of microRNAs in thyroid cancer sugg...

ea0035p1128 | Thyroid Cancer | ECE2014

Next-generation sequencing reveals a novel thyroglobulin-embedded microRNA gene deregulated in papillary thyroid carcinoma

Kolanowska Monika , Wojcicka Anna , Kubiak Anna , Swierniak Michal , Maciag Monika , Wiechno Wieslaw , Jazdzewski Krystian

Introduction: Papillary Thyroid Carcinoma (PTC) exhibits activation of MAPK (Mitogen-activated protein kinases) pathway, leading to uncontrolled cellular division and growth. Concomitantly, thyroid tumors exhibit aberrant expression of numerous microRNAs, which are non-coding RNAs that inhibit expression of protein-coding genes. Employing next-generation sequencing (NGS), we revealed comprehensive miRNA profiles of normal thyroid and PTC, and identified putative novel microRNA...

ea0022p431 | Endocrine tumours &amp; neoplasia (<emphasis role="italic">Generously supported by Novartis</emphasis>) | ECE2010

The Role of miRNA in reduction of type I 5’-iodothyronine deiodinase expression (D1) in renal clear cell carcinoma (ccRCC)

Boguslawska Joanna , Master Adam , Wojcicka Anna , Poplawski Piotr , Piekielko-Witkowska Agnieszka , Nauman Alicja

Type 1 deiodinase (D1) catalyses deiodination of tyroxine (T4), which leads either to synthesis of triiodothyronine or reverse triiodothyronine (rT3). Triiodothyronine (T3) regulates the expression of many tumour suppressor genes and oncogenes. We previously revealed that the expression of the whole pool of D1 transcripts was dramatically lowered in ccRCC tissues. One of the mechanism resulting in this aberration could be miRNA-mediated repress...

ea0022p692 | Obesity | ECE2010

Assessment of correlations between IL-18, CRP and selected adrenal androgens serum levels according to the anthropometrical and biochemical indices of metabolic syndrome (MS) in ageing men

Herman Waldemar , Lecka Katarzyna , Kaufman Elzbieta , Wojcicka Marlena , Kramer Lucyna , Losy Jacek

Aims: The aim of our study was to assess the relationships between systemic markers of general inflammation: interleukin 18 (IL-18) and C-reactive protein (CRP) and dehydroepiandrosterone (DHEA) as well as dehydroepiandrosterone sulphate (DHEA-S) serum levels, in addition to the anthropometrical and biochemical indices of metabolic syndrome (MS) in men over the age of 40.Patients and methods: In 271 randomly chosen men aged 40 to 80 years living in Lubus...

ea0019oc34 | Thyroid, reproduction and endocrine tumours | SFEBES2009

Reduction of type I 5′-iodothyronine deiodinase activity and mRNA level in renal clear cell carcinoma (ccRCC): potential role of 3′ UTR and miRNA

Boguslawska JB , Master A , Piekielko-Witkowska A , Wojcicka A , Brozda I , Poplawski P , Macke-Nauman A

Type 1 deiodinase (D1) catalyses synthesis of triiodothyronine (T3) which regulates the expression of many tumor suppressor genes and oncogenes. We previously revealed that the expression of the whole pool of D1 transcripts was dramatically lowered in ccRCC tissues. One of the mechanims resulting in this aberration could be miRNA-mediated repression of target mRNAs. The aim of the study was 1) to analyze the expression of miRNA binding to 3′UTR of D1 in ccRCC; 2) ...